| 1 | TNFSF13B
                
             💬 | 4件: Cytokine-cytokine receptor interactionCytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Intestinal immune network for IgA production, Rheumatoid arthritis | BelimumabBelimumab
                
             💬 | Belimumab | 13件: 1111, 13, 43, 44, 46, 49, 51, 53, 63, 66, 222, 296, 300 💬 | 
| 2 | CSF3R
                
             💬 | 5件: Cytokine-cytokine receptor interactionCytokine-cytokine receptor interaction, PI3K-Akt signaling pathway, JAK-STAT signaling pathway, Hematopoietic cell lineage, Pathways in cancer | FilgrastimFilgrastim
                
             💬 | Filgrastim | 35件: 22, 6, 11, 13, 16, 22, 25, 26, 28, 34, 35, 36, 38, 40, 41, 42, 45, 46, 47, 49, 51, 57, 60, 62, 65, 85, 96, 113, 164, 256, 283, 284, 285, 296, 331 💬 | 
| 3 | ADRA1D
                
             💬 | 6件: Calcium signaling pathwayCalcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | NoradrenalineNoradrenaline
                
             💬 | Norepinephrine | 2件: 2222, 296 💬 | 
| 4 | ADRA1B
                
             💬 | 6件: Calcium signaling pathwayCalcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | NoradrenalineNoradrenaline
                
             💬 | Norepinephrine | 2件: 2222, 296 💬 | 
| 5 | ADRA1A
                
             💬 | 7件: Calcium signaling pathwayCalcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Vascular smooth muscle contraction, Salivary secretion | NoradrenalineNoradrenaline
                
             💬 | Norepinephrine | 2件: 2222, 296 💬 | 
| 6 | ADRA2A
                
             💬 | 2件: cGMP-PKG signaling pathwaycGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | NoradrenalineNoradrenaline
                
             💬 | Norepinephrine | 2件: 2222, 296 💬 | 
| 7 | ADRA2B
                
             💬 | 2件: cGMP-PKG signaling pathwaycGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | NoradrenalineNoradrenaline
                
             💬 | Norepinephrine | 2件: 2222, 296 💬 | 
| 8 | ADRA2C
                
             💬 | 2件: cGMP-PKG signaling pathwaycGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction | NoradrenalineNoradrenaline
                
             💬 | Norepinephrine | 2件: 2222, 296 💬 | 
| 9 | ADRB1
                
             💬 | 11件: Calcium signaling pathwayCalcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy | NoradrenalineNoradrenaline
                
             💬 | Norepinephrine | 2件: 2222, 296 💬 | 
| 10 | ADRB1
                
             💬 | 11件: Calcium signaling pathwayCalcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Gap junction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation, Dilated cardiomyopathy | PropranololPropranolol
                
             💬 | Propranolol | 6件: 66, 158, 167, 227, 278, 296 💬 | 
| 11 | ADRB2
                
             💬 | 9件: Calcium signaling pathwayCalcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation | NoradrenalineNoradrenaline
                
             💬 | Norepinephrine | 2件: 2222, 296 💬 | 
| 12 | ADRB2
                
             💬 | 9件: Calcium signaling pathwayCalcium signaling pathway, cGMP-PKG signaling pathway, cAMP signaling pathway, Neuroactive ligand-receptor interaction, Adrenergic signaling in cardiomyocytes, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation | PropranololPropranolol
                
             💬 | Propranolol | 6件: 66, 158, 167, 227, 278, 296 💬 | 
| 13 | ADRB3
                
             💬 | 8件: Calcium signaling pathwayCalcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Thermogenesis, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation | NoradrenalineNoradrenaline
                
             💬 | Norepinephrine | 2件: 2222, 296 💬 | 
| 14 | ADRB3
                
             💬 | 8件: Calcium signaling pathwayCalcium signaling pathway, cGMP-PKG signaling pathway, Neuroactive ligand-receptor interaction, Thermogenesis, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Chemical carcinogenesis - receptor activation | PropranololPropranolol
                
             💬 | Propranolol | 6件: 66, 158, 167, 227, 278, 296 💬 | 
| 15 | GABRA1
                
             💬 | 6件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | PropofolPropofol
                
             💬 | Propofol | 9件: 66, 21, 22, 34, 46, 70, 75, 98, 296 💬 | 
| 16 | GABRA2
                
             💬 | 6件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | PropofolPropofol
                
             💬 | Propofol | 9件: 66, 21, 22, 34, 46, 70, 75, 98, 296 💬 | 
| 17 | GABRA3
                
             💬 | 6件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | PropofolPropofol
                
             💬 | Propofol | 9件: 66, 21, 22, 34, 46, 70, 75, 98, 296 💬 | 
| 18 | GABRA4
                
             💬 | 6件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | PropofolPropofol
                
             💬 | Propofol | 9件: 66, 21, 22, 34, 46, 70, 75, 98, 296 💬 | 
| 19 | GABRA5
                
             💬 | 6件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | PropofolPropofol
                
             💬 | Propofol | 9件: 66, 21, 22, 34, 46, 70, 75, 98, 296 💬 | 
| 20 | GABRA6
                
             💬 | 6件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Taste transduction, Morphine addiction, Nicotine addiction | PropofolPropofol
                
             💬 | Propofol | 9件: 66, 21, 22, 34, 46, 70, 75, 98, 296 💬 | 
| 21 | GABRB1
                
             💬 | 6件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | PropofolPropofol
                
             💬 | Propofol | 9件: 66, 21, 22, 34, 46, 70, 75, 98, 296 💬 | 
| 22 | GABRB2
                
             💬 | 6件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | PropofolPropofol
                
             💬 | Propofol | 9件: 66, 21, 22, 34, 46, 70, 75, 98, 296 💬 | 
| 23 | GABRB3
                
             💬 | 6件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, Serotonergic synapse, GABAergic synapse, Morphine addiction, Nicotine addiction | PropofolPropofol
                
             💬 | Propofol | 9件: 66, 21, 22, 34, 46, 70, 75, 98, 296 💬 | 
| 24 | GABRD
                
             💬 | 5件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | PropofolPropofol
                
             💬 | Propofol | 9件: 66, 21, 22, 34, 46, 70, 75, 98, 296 💬 | 
| 25 | GABRE
                
             💬 | 5件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | PropofolPropofol
                
             💬 | Propofol | 9件: 66, 21, 22, 34, 46, 70, 75, 98, 296 💬 | 
| 26 | GABRG1
                
             💬 | 5件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | PropofolPropofol
                
             💬 | Propofol | 9件: 66, 21, 22, 34, 46, 70, 75, 98, 296 💬 | 
| 27 | GABRG2
                
             💬 | 5件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | PropofolPropofol
                
             💬 | Propofol | 9件: 66, 21, 22, 34, 46, 70, 75, 98, 296 💬 | 
| 28 | GABRG3
                
             💬 | 5件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | PropofolPropofol
                
             💬 | Propofol | 9件: 66, 21, 22, 34, 46, 70, 75, 98, 296 💬 | 
| 29 | GABRP
                
             💬 | 5件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | PropofolPropofol
                
             💬 | Propofol | 9件: 66, 21, 22, 34, 46, 70, 75, 98, 296 💬 | 
| 30 | NR3C1
                
             💬 | 1件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction | DexamethasoneDexamethasone
                
             💬 | Dexamethasone | 22件: 1313, 14, 16, 28, 35, 46, 53, 63, 64, 65, 70, 81, 84, 96, 97, 162, 222, 235, 257, 283, 296, 299 💬 | 
| 31 | NR3C1
                
             💬 | 1件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction | MethylprednisoloneMethylprednisolone
                
             💬 | Methylprednisolone | 46件: 22, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 95, 96, 97, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296 💬 | 
| 32 | NR3C1
                
             💬 | 1件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction | PrednisolonePrednisolone
                
             💬 | Prednisolone | 42件: 33, 11, 13, 14, 25, 26, 35, 38, 39, 40, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 107, 113, 145, 162, 222, 269, 271, 296, 299, 300 💬 | 
| 33 | PPARA
                
             💬 | 10件: PPAR signaling pathwayPPAR signaling pathway, cAMP signaling pathway, Adipocytokine signaling pathway, Glucagon signaling pathway, Insulin resistance, Non-alcoholic fatty liver disease, Alcoholic liver disease, Hepatitis C, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy | BezafibrateBezafibrate
                
             💬 | Bezafibrate | 7件: 2020, 93, 94, 160, 296, 316, 324 💬 | 
| 34 | GABRQ
                
             💬 | 5件: Neuroactive ligand-receptor interactionNeuroactive ligand-receptor interaction, Retrograde endocannabinoid signaling, GABAergic synapse, Morphine addiction, Nicotine addiction | PropofolPropofol
                
             💬 | Propofol | 9件: 66, 21, 22, 34, 46, 70, 75, 98, 296 💬 | 
| 35 | PTGS2
                
             💬 | 22件: Arachidonic acid metabolismArachidonic acid metabolism, Metabolic pathways, NF-kappa B signaling pathway, VEGF signaling pathway, C-type lectin receptor signaling pathway, IL-17 signaling pathway, TNF signaling pathway, Retrograde endocannabinoid signaling, Serotonergic synapse, Ovarian steroidogenesis, Oxytocin signaling pathway, Regulation of lipolysis in adipocytes, Alzheimer disease, Pathways of neurodegeneration - multiple diseases, Leishmaniasis, Human cytomegalovirus infection, Human papillomavirus infection, Kaposi sarcoma-associated herpesvirus infection, Pathways in cancer, Chemical carcinogenesis - DNA adducts, MicroRNAs in cancer, Small cell lung cancer | MeloxicamMeloxicam
                
             💬 | Meloxicam | 4件: 4646, 49, 271, 296 💬 | 
| 36 | SLC10A1
                
             💬 | 2件: Bile secretionBile secretion, Hepatitis B | MaralixibatMaralixibat
                
             💬 | Maralixibat | 3件: 296296, 297, 338 💬 | 
| 37 | SLC10A2
                
             💬 | 1件: Bile secretionBile secretion | MaralixibatMaralixibat
                
             💬 | Maralixibat | 3件: 296296, 297, 338 💬 | 
| 38 | SLC10A2
                
             💬 | 1件: Bile secretionBile secretion | OdevixibatOdevixibat
                
             💬 | Odevixibat | 3件: 296296, 297, 338 💬 | 
| 39 | MS4A1
                
             💬 | 1件: Hematopoietic cell lineageHematopoietic cell lineage | RituximabRituximab
                
             💬 | Rituximab | 48件: 1111, 13, 14, 19, 26, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬 | 
| 40 | KEAP1
                
             💬 | 6件: Ubiquitin mediated proteolysisUbiquitin mediated proteolysis, Parkinson disease, Pathways in cancer, Chemical carcinogenesis - reactive oxygen species, Hepatocellular carcinoma, Fluid shear stress and atherosclerosis | Dimethyl fumarateDimethyl fumarate
                
             💬 | Dimethyl fumarate | 5件: 1313, 49, 51, 86, 296 💬 | 
| 41 | NR1H4
                
             💬 | 1件: Bile secretionBile secretion | UrsodiolUrsodiol
                
             💬 | Ursodeoxycholic acid | 14件: 66, 8, 20, 46, 67, 84, 93, 94, 95, 96, 97, 234, 296, 299 💬 | 
| 42 | NR1H4
                
             💬 | 1件: Bile secretionBile secretion | Obeticholic acidObeticholic acid
                
             💬 | Obeticholic acid | 3件: 9393, 265, 296 💬 |